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Copyright © 2011 JCBN 2011 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. Mulberry is commonly used as silkworm diet and an alternative
medicine in Japan and China, has recently reported to contain
many antioxidative flavanoid compounds and having the free
radical scavenging effects. Antioxidants reduce cardiac oxidative
stress and attenuate cardiac dysfunction in animals with pacing 
induced congestive heart failure. Hence we investigated the cardio 
protective effect of mulberry leaf powder in rats with experi 
mental autoimmune myocarditis. Eight week old Lewis rats
immunized with cardiac myosin were fed with either normal
chow or a diet containing 5% mulberry leaf powder and were
examined on day 21. ML significantly decreased oxidative stress,
myocyte apoptosis, cellular infiltration, cardiac fibrosis, mast cell
density, myocardial levels of sarco/endo plasmic reticulum Ca2+
ATPase2, p22phox, receptor for advanced glycation end products,
phospho p38 mitogen activated protein kinase, phospho c Jun
NH2 terminal protein kinase, glucose regulated protein78,
caspase12 and osteopontin levels in EAM rats. These results may
suggest that mulberry diet can preserve the cardiac function in
experimental autoimmune myocarditis by modulating oxidative
stress induced MAPK activation and further afford protection
against endoplasmic reticulum stress mediated apoptosis.
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Introduction In patients with heart failure (HF), increase in plasma
biochemical markers of oxidative stress has been reported.
There is a definitive correlation between oxidative stress and
ventricular dysfunction. Furthermore, ventricular remodeling and
progressive dilation leading to end-stage HF may be mediated by
oxygen-derived free radicals. Therefore, it is likely that reactive
oxygen species (ROS) are involved in not only the pathogenesis
but also the active progression of HF.(1) Acute myocarditis is a
potentially lethal disease and frequently precedes the development
of acute and chronic HF. Some patients with myocarditis show a
fulminant course and die of intractable cardiogenic shock, and
the treatment strategy for the disease is still unresolved.(2) A model
of rat experimental autoimmune myocarditis (EAM) resembles
human giant cell myocarditis, and the recurrent form of EAM
leads to dilated cardiomayopathy.(3) Recent evidence suggests that
oxidative stress and myocardial remodeling including myocardial
apoptosis play important roles in the progression of EAM.(4,5)
Oxidative stress is known to induce apoptosis in a variety of cell
types by activating intracellular cell death signaling cascades
including the well-characterized mitogen activated protein kinase
(MAPK) pathways in the heart.(6,7) There is growing evidence that
ROS may cause cell death via mediation of MAPK under various
oxidative conditions. Oxidative stress in the cardiomyocyte can
further produce endoplasmic reticulum (ER) stress. Both oxidative
stress involving MAPK pathway and ER stress lead to myocardial
apoptosis and myocardial damage.
Mulberry (Morus alba L., family Moraceae) leaves, which are
commonly used a silkworm diet, contain various nutritional
components. Among them, flavonoids and moracins are known
to have effects as antioxidants or free radical scavengers.(8) It
contains many phenolic antioxidants that can reduce cardio-
vascular disease.(9) Dietary mulberry has also been reported to
have hypoglycemic, hypolipidemic, and antioxidant effects.(10)
Mulberry showed relatively high antioxidant activity on comparison
with 52 kinds of edible plant products in Japan by LDL oxidation
assay.(11) Because of these interesting results we have decided to
examine the effects of dietary administration of mulberry leaf
powder (ML) on EAM focusing on the antioxidative effects
followed by modulating influence on ER stress in cardiac dysfunc-
tion.
Materials and Methods
Animals. Eight-week old male Lewis rats were purchased
from Charles River Japan Inc., Kanagawa, Japan and were main-
tained in our animal facilities. Throughout the studies, all the
animals were treated in accordance with the guidelines for animal
experiments as laid out by our institute.
Induction of EAM. Cardiac myosin was prepared from the
ventricular muscle of porcine hearts as previously described.(12) It
was dissolved in phosphate buffered saline (PBS) at 5 mg/ml and
emulsified with and equal volume of complete Freund’s adjuvant
supplemented with 11 mg/ml Mycobacterium tuberculosis H37
RA (Difco, Detriot, Michigan). On day 0, the rats received a single
immunization at two subcutaneous sites (both footpads) with a
total of 0.2 ml of emulsion for each rat.
Test dose. The immunized rats were randomly divided into
two groups, control and 5% ML, and were started on the test diets.
The control group was fed a normal powder chow diet, whereas
the 5% ML received a normal powder diet supplemented with 5%
w/w of ML (Taimatsu Co., Gosen, Japan) on 0 day of immuniza-
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tion. Age-matched Lewis rats without immunization used as
normal group and fed with normal powder diet.
Hemodynamic and echocardiography. On day 21, cardiac
function of each rat was measured by hemodynamic study and
cardiac pressure changes were recorded as described previously.(12)
Similarly heart dimensions were studied using echocardiography
followed by the calculation of ejection fraction (EF) and fractional
shortening (FS).(12)
Histopathological analysis. After the analysis of myocar-
dial function, rats were sacrificed and the hearts were excised and
weighed. The heart weight (HW) to body weight (BW) ratios was
calculated. The excised hearts were cut into about 2-mm trans-
verse slices and fixed in 10% formalin. After being embedded in
paraffin, several transverse sections were prepared from the
ventricle, and stained with hematoxylin-eosin (H-E) and Azan-
Mallory. Infiltration of inflammatory cells was examined in the H-
E stained slides viewed under a high-power light microscope.(13,14)
The area of myocardial fibrosis was measured quantitatively using
a color image analyzer (CIA-102; Olympus, Tokyo, Japan),
making use of the differences in the Azan-Mallory stained color
(blue fibrotic area opposed to red myocardium). The results were
presented as the ratio of the fibrotic area to the whole area of
myocardium.
Mast cell staining and quantification. Histochemical 
staining with toluidine blue was performed to identify mast
cells.(15) For toluidine blue staining, slides of paraffinized sections
of the mid ventricle were dewaxed, dehydrated and incubated with
0.05% w/v toluidine blue for 30 min followed by counterstaining
with 0.01% w/v eosin for 1 min. Metachromatic staining of mast
cell granules was handy to identify these cells. Mast cell density
was quantified by counting the number of toluidine blue-positive
mast cells per field (100X). At least 15 fields were included from
each slide for counting.
Western blotting analyses. Protein lysate was prepared
from heart tissue as described previously.(16) The total protein
concentration in samples was measured by the bicinchoninic acid
method. For Western blotting experiments, 30 µg of total protein
was loaded in each lane and proteins were separated by SDS-
PAGE (200 V for 40 min) and electrophoretically transferred to
nitrocellulose filters (semi-dry transfer at 10 V for 30 min). Filters
were blocked with 5% non-fat dry milk in Tris buffered saline
(20 mM Tris, pH 7.6, 137 mM NaCl) with 0.1% Tween 20,
washed, and then incubated with primary antibody. Primary anti-
bodies employed include: glyceraldehyde-3-phosphate dehydro-
genase (GAPDH), p22phox, receptor for advanced glycation end
products (RAGE), sarcoendoplasmic reticulum Ca2+ ATPase2
(SERCA2), phospho-p38 MAPK, c-Jun NH2-terminal protein
kinase (JNK), phospho-JNK, Glucose regulated protein 78
(GRP78), caspase12 and osteopontin (OPN). All the antibodies
were purchased either from Cell Signaling Technology Inc., MA,
USA or Santa Cruz Biotechnology Inc., CA. After incubation
with the primary antibody, the bound antibody was visualized
with horseradish peroxidase-coupled secondary antibodies (Santa
Cruz Biotechnology) and chemiluminescence developing agents
(Amersham Biosciences, Buckinghamshire, UK). For western
blotting analysis, all primary antibodies were used at a dilution of
1:1000 and secondary antibodies were used at a dilution of 1:5000.
Films were scanned and band densities were quantified by densito-
metric analysis using Scion image software (Epson GT-X700;
Tokyo, Japan).
Detection of apoptosis. Frozen left ventricular (LV) tissues
embedded in OCT compound were cut into 4 µM thick sections
and fixed in 4% paraformaldehyde (pH 7.4) at room temperature.
Terminal transferase-mediated DNA nick end labeling (TUNEL)
assay was performed as specified in the in situ apoptosis detection
kit (Takara Bio Inc. Shiga, Japan). Sections were mounted and
examined using light microscopy. For each animal, five sections
were scored for apoptotic nuclei. Only nuclei that were clearly
located in cardiac myocytes were considered.
Statistical analysis. All values are expressed as mean ± SEM.
Statistical analysis of differences between the groups was per-
formed by one-way ANOVA, followed by Tukey’s multiple
comparison method. A value of p<0.05 was considered statisti-
cally significant.
Results
ML treatment improved cardiac structure and function.
The present study identified a significant suppression of the
cardiac function in the EAM rats after three weeks of cardiac
myosin injection. There was a significant impairment of the
systolic and diastolic components of cardiac contraction as per the
hemodynamic and echocardiographic analyses. The control rats
demonstrated LV remodeling with increased LV end diastolic
pressure (LVEDP), LV dimension in systole (LVDs), LV dimen-
sion in diastole (LVDd) and reduced FS in vehicle-treated EAM
rats in comparison to control, indicating the impairment of
myocardial function. ML treatment has reversed these changes
significantly (Table 1). There was a marked inflammatory cellular
infiltration and increased myocardial cell size in the control group
as identified by histochemical analysis using hematoxylin-eosin
staining whereas the ML treated rats showed normal cardiac archi-
tecture without much inflammatory cellular infiltration (Fig. 1A).
ML afforded protection from oxidative stress. The un-
treated rats showed a marked elevation in the myocardial expres-
sion of p22phox, which is a membrane-bound NADPH oxidase
subunit indicating the oxidative stress mediated by cardiac
myosin. This elevation was prevented by the ML supplementation
in the treated rats confirming the possible protection of the EAM
rats from oxidative stress. Similarly the expression of RAGE in
the myocardium of the ML treated rats were significantly less
when compared with the control rats.
ML treatment modulates MAPK pathway. There was a
significant increase in the expression of p38MAPK and p-JNK in
the control rats. This result suggests that oxidative stress mediates
the stimulation of MAPK pathway. ML supplementation through
diet modified this change in the EAM rats. Protein expression of
both these markers was attenuated significantly in the ML treated
rats.
ML afforded protection from ER stress. GRP78 is a marker
of ER stress whose expression is reported to be increased in the
EAM rats. ER stress leads to the activation of caspase 12 and other
markers involved in the myocardial changes associated with
several autoimmune reactions. In our study with EAM rats also
revealed the involvement of ER stress as evidenced by significant
increase in the myocardial GRP78 and caspase12 expression.
Prevention of ER stress is one of the strategies involved in the
reduction of myocardial complications of EAM. In the present
study ML treated animals had shown significant attenuation of
these ER stress markers when compared with the control group
(Fig. 2).
ML afforded protection from myocardial apoptosis.
Further ER stress mediated apoptosis was confirmed by the
TUNEL staining of the myocardial tissue slices where the control
animals presented numerous TUNEL positive apoptotic nuclei
and ML treated animals showed less apoptosis on comparison
with the control group (Fig. 1 B and E).
ML treatment decreased myocardial fibrosis. Several 
areas of the control group rat myocardial tissue were replaced by
the fibrotic tissue as stained by the Azan-Mallory technique which
was prevented by the ML supplementation (Fig. 1 C and F).
Extensive myocardial fibrosis was also confirmed by the expres-
sion of OPN. Control animals showed significantly increased
expression of OPN in the myocardial protein lysate when compared
to the normal rats. This increased expression was attenuated by
the ML supplementation. The stained tissue sections of ML treated J. Clin. Biochem. Nutr. | March 2012 | vol. 50 | no. 2 | 141
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Table 1. Changes in histopathological, hemodynamic and echocardiographic parameters after 3 weeks of treat 
ment with mulberry leaf powder in rats with EAM
BW, body weight; HW, heart weight; HW/BW, ratio of heart weight to body weight; CVP, central venous pressure;
AP, arterial pressure; LVP, left ventricular pressure; LVEDP, left ventricular end diastolic pressure; dP/dt, rate of
intraventricular pressure change; HR, heart rate; LVDd, left ventricular dimension in diastole; LVDs, left ventricular
dimension in systole; FS, fractional shortening; EF, ejection fraction; Normal, age matched untreated rats; Control,
rats with EAM treated with vehicle; Mulberry 5%, rats with EAM treated with ML (5%) Results are expressed as
mean ± SEM. ##p<0.01 vs normal; *p<0.05 and **p<0.01 vs control.
Normal Control Mulberry 5%
Histopathology
BW (g) 328.4 ± 1.94 228 ± 4.55## 236 ± 4.76
HW (g) 0.94 ± 0.01 1.27 ± 0.09## 1.21 ± 0.06
HW/BW (g/kg) 2.86 ± 0.04 5.57 ± 0.34## 5.13 ± 0.34
Area of fibrosis (%) 3.4 ± 0.5 78.57 ± 4.04## 44 ± 2.45**
Hemodynamic data
CVP 0.73 ± 0.37 10.58323 ± 0.66## 6.48 ± 4.90**
AP 113.88 ± 2.08 38.96667 ± 0.63## 66.63 ± 3.46
LVP 130.5 ± 6.60 54.79 ± 1.61## 91 ± 1.25**
LVEDP 1.98 ± 0.81 14.28 ± 0.14## 10.72 ± 0.57*
dP/dt max 9013 ± 100.80 2891.66 ± 22.92## 4389.5 ± 568.5*
dP/dt min 8422 ± 615.19 2167.33 ± 50.22## 3252 ± 226
Echocardiographic data
HR (beats/min) 437.58 ± 6.56 237.33 ± 14.43## 342.5 ± 30.5*
LVDd (mm) 6.2 ± 0.37 6.61 ± 0.53 7.7 ± 0.53
LVDs (mm) 3.8 ± 0.32 6.1 ± 0.5## 5 ± 0.32
FS (%) 42.7 ± 27 . 1 ± 0.59## 14.4 ± 1.87*
EF (%) 79 ± 2.1 18.6 ± 1.49## 34.8 ± 3.76**
Fig. 1. A–D, Hematoxylin and eosin staining depicting interstitial edema, vacuolization and degeneration of cardiac fibers, TUNEL staining
depicting myocardial apoptosis, Azan Mallory staining for fibrosis (blue area) and cross sectional cardiac tissue slices with Toluidine blue staining
depicting the mast cells respectively (×200). E–G, Bar graph showing the TUNEL positive apoptotic cells (25 fields), % fibrosis and number of mast
cells (25 fields). Each bar represents mean ± SEM. Normal, age matched normal rats; Control, Immunized rats fed with normal diet; ML 5%,
Immunized rats administered with normal diet with 5% Mulberry leaf powder. ***p<0.001 vs normal; ###p<0.001 vs control.doi: 10.3164/jcbn.11 44
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rats showed near normal cardiac architecture with least fibrotic
tissue replacement.
ML treatment normalized the myocardial calcium han 
dling. Rats with EAM showed impaired calcium handling as
evidenced by the significant reduction of the myocardial SERCA2
level, which is essential for the maintenance of calcium movement
across the myocardial cells. ML supplemented rats showed
significant increase in the expression of SERCA2 in the cardio-
myocytes indicating the protection offered by ML against the
cardiac myosin induced defect in myocardial calcium handling.
ML treatment decreased the mast cell count. The number
of mast cells present in the myocardial tissue slices of all the
groups of rats was identified using toluidine blue staining.
Toluidine blue positive mast cell count was significantly higher in
the EAM control rats when compared with the normal whereas
ML treated showed possible protection from this increase con-
firmed by the significant decrease in the mast cell count when
compared with the control animals (Fig. 1 D and G).
Discussion
Oxidative stress plays a major role in the pathogenesis of
EAM(17) and several antioxidants were screened for their protec-
tive role in the treatment of EAM. We have carried out the study
with dietary supplementation of ML in cardiac myosin induced
EAM rats. The hemodynamic and echocardiographic analyses
demonstrated LV remodeling with LVEDP, LVDs, LVDd and
reduced FS in vehicle-treated EAM rats in comparison to control,
indicating impaired systolic and diastolic function of the myo-
cardium. ML treatment produced significant beneficial effects on
hemodynamic properties by reversing the ventricular pressure
changes, fibrosis, EF and FS significantly.
Mast cells participate in the acute inflammatory reaction and the
onset of ventricular remodeling associated with acute myocarditis
and that the inhibition of their function may be therapeutic in this
disease.(18) Several flavonoids including quercetin and myricetin
were reported to inhibit mast cell activation.(19) Similarly the
number of mast cells in the myocardium of the ML treated rats was
reduced significantly than the control rats evidenced by histo-
Fig. 2. Myocardial expressions of phospho p38 MAPK, p38 MAPK, phospho SAPK/JNK, SAPK/JNK, p22phox, SERCA2, GRP78, caspase12, OPN, RAGE
and GAPDH. A, Representative western blots showing specific bands for phospho p38 MAPK, p38 MAPK, phospho SAPK/JNK, SAPK/JNK, p22phox,
SERCA2, GRP78, caspase12, OPN, RAGE and GAPDH as an internal control. Equal amounts of protein sample (30 μg) obtained from whole ventricular
homogenate were applied in each lane. These bands are representative of five separate experiments. B–H, Densitometric data of protein analysis. B
and C, The mean density values of phospho p38 MAPK, phospho SAPK/JNK, expressed as ratios relative to their respective unphosphorylated
protein mean density values. D–I, The mean density values of p22phox, SERCA2, GRP78, caspase12, OPN and RAGE expressed as ratios relative to that
of GAPDH. Each bar represents mean ± SEM. Normal, age matched normal rats; Control, Immunized rats fed with normal diet; ML 5%, Immunized
rats administered with normal diet with 5% Mulberry leaf powder. *p<0.05, **p<0.01, ***p<0.001 vs normal; #p<0.05,  ##p<0.01,  ###p<0.001 vs
control. J. Clin. Biochem. Nutr. | March 2012 | vol. 50 | no. 2 | 143
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pathological analysis (Fig. 1). In line with several studies with
antioxidants against mast cells in EAM, our study also confirmed
that ML a rich source of antioxidants has a protective role in EAM.
NADPH oxidases are the major sources of superoxide in
vascular cells and myocytes.(20) Several membrane-bound and
cytosolic subunits of them are implicated in oxidative stress.
Pathogenic inflammatory reaction stimulates these subunits and
produces ROS mediated tissue damage. Antioxidants lower the
NADPH oxidase activity and reduce the levels of its preexisting
subunits. Dietary supplementation of several plant products rich in
anthocyanins were reported to suppress the oxidative stress.(21) It
was reported that ML, a good source of antioxidants including
anthocyanins, can ameliorate oxidative stress by inhibiting NADPH
oxidase subunits(22) and thus we have screened the effect of ML
treatment on a membrane bound NADPH oxidase subunit, p22phox
expression in the myocardium. There was a significant increase in
the myocardial p22phox level of control rats indicating the increased
level of oxidative stress and ML treatment attenuated this increase
significantly (Fig. 2) ensuring that ML can modulate the oxidative
stress mediated by NADPH oxidase. Further, the involvement
of oxidative stress was confirmed by assessing the myocardial
expression of RAGE. Oxidation of cellular proteins and lipids
produce advanced glycation end products,(23) which act as ligand
for RAGE and lead to tissue damage.(24) RAGE expression was
significantly suppressed in the ML treated rats (Fig. 2) indicating
the protection offered by its supplementation. These results
suggest that ML treatment can protect the animals from cardiac
damage induced by oxidative stress following EAM.
Oxidative stress and MAPKs are involved in myocardial
remodeling and play a major role in the development of cardio-
toxicity.(25) It was reported that mulberry extracts can modulate
the MAPK pathway and induce antioxidant defense system.(21) In
order to investigate the possible relationship between NADPH
oxidase and the activation of redox-sensitive kinases, we mea-
sured the phosphorylation of p38 MAPK, and SAPK/JNK. The
p38 MAPK is a subfamily of the MAPK superfamily and is stress
responsive. Activation of p38 MAPK is associated with accumula-
tion of reactive oxygen species generated under stress condi-
tions.(26) Various antioxidants were reported to inhibit JNK and
p38 MAPK activation.(27) The expression of phospho-p38 MAPK
and phospho-JNK were significantly increased in the diseased
animals whereas ML supplementation has provided protection
from the cardiac damage evidenced by decreased levels of both
proteins in this pathway (Fig. 2). These results confirm the corre-
lation between oxidative stress and MAPK pathway. ML treatment
can protect the animals from cardiac damage induced by oxidative
stress following MAPK activation.
ER stress has been attracting considerable attention since it
triggers several inflammatory disorders. There are reports
suggesting that oxidative stress can lead to ER stress and show
increased expression of ER stress markers.(6) In response to ER
stress, there is a marked upregulation of ER chaperone like
GRP78. Cell apoptosis can proceed through caspase12, which is
localized in the ER and activated by ER stress.(28) This stress
includes disruption of ER calcium homeostasis and accumulation
of excessive proteins in ER.(29) It was reported that quercetin
which is the major component of ML suppressed the ER stress
caused by calcium dynamics dysregulation.(30) In the present study
there was a significant increase in the myocardial levels of GRP78
and caspase12 in the control rats, pointing the ER stress mediated
by EAM. In line with the reports of quercetin, ML supplemented
rats also showed reduced levels of both GRP78 and caspase12
indicating the prevention of ER stress.
Dysregulated apoptosis has been implicated in many diseases
including cancer, autoimmune and degenerative disorders, and
is now emerging as a likely suspect in cardiomyocyte death.(31)
Identification of TUNEL positive apoptotic cells in the myo-
cardium provides a useful tool for determining the intensity of the
myocardial damage.(32) There are several reports indicating the
increase in number of apoptotic cells in the myocardium of the
EAM rats and our results with histopathological study also
confirmed the increase in apoptotic cells present in the control
rats. Our study also revealed the antiapoptotic role of ML by
decreasing the number of TUNEL positive cells. From these data
we can establish that ML can prevent apoptosis in EAM rats and
protect them from myocardial damage.
Calcium dynamics dysregulation was identified in the control
rats evidenced by the decreased myocardial levels of SERCA2.
The sequence of events following oxidative stress leads to an
inotropic increase in intracellular calcium concentrations.(33) The
coordinating role of calcium in cardiac hypertrophic response has
been reported.(26) SERCA2 is chiefly responsible for the regulation
of intracellular calcium ion concentration in cardiac myocytes
during the excitation-contraction cycle.(33) Dysregulation of the
intracellular calcium content and the myocardial contractility
should lead to the development of myocarditis.(34) Conversely
OPN is abundantly expressed by infiltrating macrophages during
wound healing and has been implicated in cardiac tissue repair.(35)
High expression levels of OPN in acute myocarditis are associated
with the development of extensive fibrosis.(36) It was reported
that quercetin, an antioxidant flavonoid compound found in ML,
normalized the calcium movement in transgenic mouse model.(37)
In our study, the myocardial level of SERCA2 was significantly
decreased and OPN level was increased in the control rats which
was found to be normalized in the ML treated group (Fig. 2). Thus
ML treated rats can handle calcium movement in the cardiac
cells properly to maintain normal cardiac function.
Conclusion
In EAM, the pathologic involvement of oxidative stress, ER
stress, improper calcium handling and apoptosis were confirmed
by our study. An interesting view is that all of these changes are
inter-related as both oxidative stress and reduced SERCA2 expres-
sion lead to ER stress and subsequently to apoptosis and cardio-
vascular damage. It was reported that agents with effect on sub-
cellular remodeling, oxidative stress, apoptosis and defect in
calcium handling are important in preventing the alterations in the
failing heart.(38) ML treatment showed possible protection from the
oxidative stress in the EAM rats, which may be mainly due to its
antioxidant property and further avoided the ER stress and
myocardial apoptosis. Along with this, EAM rats treated with ML
can maintain the normal cardiac function by preserving the normal
calcium ion movement in the cardiomyocytes. The protection
afforded by the ML treatment is by blockade of ER stress either
via modulation of oxidative stress and/or SERCA2 expression in
the hearts of EAM rats.
Our study with ML provided the evidences for the protective
effect of ML on EAM rats with 21 days treatment as confirmed
by the maintenance of normal cardiac anatomy and physiology.
Mulberry leaves are known for their good antioxidant activity and
supplementation of ML with the normal diet has reversed the
changes induced by cardiac myosin, indicating the role of this
antioxidant in treating the cardiac dysfunction in EAM.
Acknowledgments
This research was supported by Yujin Memorial Grant, Ministry
of Education, Culture, Sports, Science and Technology, Japan, and
by a grant from the promotion and Mutual Aid Corporation for
Private Schools, Japan.doi: 10.3164/jcbn.11 44
©2012 JCBN
144
References
1 Keith M, Geranmayegan A, Sole MJ, et al. Increased oxidative stress in
patients with congestive heart failure. J Am Coll Cardiol 1998; 31: 1352–
1356.
2 Fuse K, Kodama M, Okura Y, et al. Predictors of disease course in patients
with acute myocarditis. Circulation 2000; 102: 2829–2835.
3 Mitsuma W, Ito M, Kodama M, et al. Cardioprotective effects of recombi-
nant human erythropoietin in rats with experimental autoimmune myocarditis.
Biochem Biophys Res Commun 2006; 344: 987–994.
4 Lowenstein CJ. Exogenous thioredoxin reduces inflammation in autoimmune
myocarditis. Circulation 2004; 110: 1178–1179.
5 Alter P, Jobmann M, Meyer E, Pankuweit S, Maisch B. Apoptosis in myo-
carditis and dilated cardiomyopathy: does enterovirus genome persistence
protect from apoptosis? An endomyocardial biopsy study. Cardiovasc Pathol
2001; 10: 229–234.
6 Zhou Y, Wang Q, Evers BM, Chung DH. Signal transduction pathways
involved in oxidative stress-induced intestinal epithelial cell apoptosis. Pediatr
Res 2005; 58: 1192–1197.
7 Zhou Y, Wang Q, Evers BM, Chung DH. Oxidative stress-induced intestinal
epithelial cell apoptosis is mediated by p38 MAPK. Biochem Biophys Res
Commun 2006; 350: 860–865.
8 Shibata Y, Kume N, Arai H, et al. Mulberry leaf aqueous fractions inhibit
TNF-alpha-induced nuclear factor kappaB (NF-kappaB) activation and lectin-
like oxidized LDL receptor-1 (LOX-1) expression in vascular endothelial
cells. Atherosclerosis 2007; 193: 20–27.
9 Chan KC, Ho HH, Huang CN, Lin MC, Chen HM, Wang CJ. Mulberry leaf
extract inhibits vascular smooth muscle cell migration involving a block of
small GTPase and Akt/NF-kappaB signals. J Agric Food Chem 2009; 57:
9147–9153.
10 El-Beshbishy HA, Singab AN, Sinkkonen J, Pihlaja K. Hypolipidemic and
antioxidant effects of Morus alba L. (Egyptian mulberry) root bark fractions
supplementation in cholesterol-fed rats. Life Sci 2006; 78: 2724–2733.
11 Enkhmaa B, Shiwaku K, Katsube T, et al. Mulberry (Morus alba L.) leaves
and their major flavonol quercetin 3-(6-malonylglucoside) attenuate athero-
sclerotic lesion development in LDL receptor-deficient mice. J Nutr 2005;
135: 729–734.
12 Kodama M, Matsumoto Y, Fujiwara M, Masani F, Izumi T, Shibata A. A
novel experimental model of giant cell myocarditis induced in rats by
immunization with cardiac myosin fraction. Clin Immunol Immunopathol
1990; 57: 250–262.
13 Thandavarayan RA, Watanabe K, Ma M, et al. Dominant-negative p38alpha
mitogen-activated protein kinase prevents cardiac apoptosis and remodeling
after streptozotocin-induced diabetes mellitus. Am J Physiol Heart Circ
Physiol 2009; 297: H911–919.
14 Thandavarayan RA, Watanabe K, Ma M, et al. 14-3-3 protein regulates Ask1
signaling and protects against diabetic cardiomyopathy. Biochem Pharmacol
2008; 75: 1797–1806.
15 Palaniyandi SS, Watanabe K, Ma M, Tachikawa H, Kodama M, Aizawa
Y. Inhibition of mast cells by interleukin-10 gene transfer contributes to
protection against acute myocarditis in rats. Eur J Immunol 2004; 34: 3508–
3515.
16 Thandavarayan RA, Watanabe K, Sari FR, et al. Modulation of doxorubicin-
induced cardiac dysfunction in dominant-negative p38α mitogen-activated
protein kinase mice. Free Radic Biol Med 2010; 49: 1422–1431.
17 Li YC, Ge LS, Yang PL, et al. Carvedilol treatment ameliorates acute
coxsackievirus B3-induced myocarditis associated with oxidative stress
reduction. Eur J Pharmacol 2010; 640: 112–116.
18 Higuchi H, Hara M, Yamamoto K, et al. Mast cells play a critical role in the
pathogenesis of viral myocarditis. Circulation 2008; 118: 363–372.
19 Park HH, Lee S, Son HY, et al. Flavonoids inhibit histamine release and
expression of proinflammatory cytokines in mast cells. Arch Pharm Res 2008;
31: 1303–1311.
20 Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H Oxidase: role in
cardiovascular biology and disease. Circ Res 2000; 86: 494–501.
21 Shih PH, Chan YC, Liao JW, Wang MF, Yen GC. Antioxidant and cognitive
promotion effects of anthocyanin-rich mulberry (Morus atropurpurea L.) on
senescence-accelerated mice and prevention of Alzheimer’s disease. J Nutr
Biochem 2010; 21: 598–605.
22 Sugimoto M, Arai H, Tamura Y, et al. Mulberry leaf ameliorates the expres-
sion profile of adipocytokines by inhibiting oxidative stress in white adipose
tissue in db/db mice. Atherosclerosis 2009; 204: 388–394.
23 Boldyrev AA. Protection of proteins from oxidative stress: a new illusion or
a novel strategy? Ann NY Acad Sci 2005; 1057: 193–205.
24 Herold K, Moser B, Chen Y, et al. Receptor for advanced glycation end
products (RAGE) in a dash to the rescue: inflammatory signals gone awry in
the primal response to stress. J Leukoc Biol 2007; 82: 204–212.
25 Tanaka K, Honda M, Takabatake T. Redox regulation of MAPK pathways
and cardiac hypertrophy in adult rat cardiac myocyte. J Am Coll Cardiol
2001; 37: 676–685.
26 Kang YJ. Cardiac hypertrophy: a risk factor for QT-prolongation and cardiac
sudden death. Toxicol Pathol 2006; 34: 58–66.
27 Kyaw M, Yoshizumi M, Tsuchiya K, Izawa Y, Kanematsu Y, Tamaki
T. Atheroprotective effects of antioxidants through inhibition of mitogen-
activated protein kinases. Acta Pharmacol Sin 2004; 25: 977–985.
28 Sun Y, Liu G, Song T, et al. Upregulation of GRP78 and caspase-12 in
diastolic failing heart. Acta Biochimi Pol 2008; 55: 511–516.
29 Nakagawa T, Zhu H, Morishima N, et al. Caspase-12 mediates endoplasmic-
reticulum-specific apoptosis and cytotoxicity by amyloid-β.  Nature 2000;
403: 98–103.
30 Natsume Y, Ito S, Satsu H, Shimizu M. Protective effect of quercetin on ER
stress caused by calcium dynamics dysregulation in intestinal epithelial cells.
Toxicology 2009; 258: 164–175.
31 Saraste A, Arola A, Vuorinen T, et al. Cardiomyocyte apoptosis in experi-
mental coxsackievirus B3 myocarditis. Cardiovasc Pathol 2003; 12: 255–
262.
32 Gill C, Mestril R, Samali A. Losing heart: the role of apoptosis in heart
disease—a novel therapeutic target? FASEB J 2002; 16: 135–146.
33 Sharaf AR, Narula J, Nicol PD, Southern JF, Khaw BA. Cardiac sarcoplasmic
reticulum calcium ATPase, an autoimmune antigen in experimental cardio-
myopathy. Circulation 1994; 89: 1217–1228.
34 Ho PD, Zechner DK, He H, Dillmann WH, Glembotski CC, McDonough
PM. The Raf-MEK-ERK cascade represents a common pathway for altera-
tion of intracellular calcium by Ras and protein kinase C in cardiac myocytes.
J Biol Chem 1998; 273: 21730–21735.
35 Shin T, Ahn M, Kim H, Kim HM, Matsumoto Y. Increased expression of
osteopontin in the heart tissue of Lewis rats with experimental autoimmune
myocarditis. J Vet Med Sci 2006; 68: 379–382.
36 Szalay G, Sauter M, Haberland M, et al. Osteopontin: a fibrosis-related
marker molecule in cardiac remodeling of enterovirus myocarditis in the
susceptible host. Circ Res 2009; 104: 851–859.
37 Soga M, Kamal FA, Watanabe K, et al. Effects of angiotensin II receptor
blocker (candesartan) in daunorubicin-induced cardiomyopathic rats. Int J
Cardiol 2006; 110: 378–385.
38 Rehsia NS, Dhalla NS. Mechanisms of the beneficial effects of beta-
adrenoceptor antagonists in congestive heart failure. Exp Clin Cardiol 2010;
15: e86–e95.